MDXH News

November kicked off with a 12 IPO week and shoe brand Allbirds (BIRD) was at the front of the flock, posting a first-day pop of 93%. 23 SPACs also went public. New issuers continued to join the pipeline, with five IPOs and 13 SPACs submitting initial filings. Two issuers postponed this past week: Russian car-sharing firm Delimobil (DMOB) and...read more

MDxHealth, a Belgian provider of genomic testing products for prostate cancer, raised $45 million by offering 3.8 million ADSs at $12, above the as-converted last close of its shares on the Euronext Brussels ($11.70). MDxHealth is a commercial-stage precision diagnostics company that provides novel prostate cancer genomic testing solutions, SelectMDx (a liquid biopsy test for...read more

Updated Monday, 11/1. The IPO market has seen double digit offerings for the past two weeks, and is scheduled to continue its streak, with 13 IPOs expected to raise $2.7 billion. Drug discovery company Evotec (EVO) plans to raise $576 million at a $9.2 billion market cap. The company aims to accelerate and improve the efficiency of the drug discovery...read more

MDxHealth, a Belgian provider of genomic testing products for prostate cancer, announced terms for its IPO on Thursday. The Herstal, Belgium-based company plans to raise $50 million by offering 3.8 million shares at  $13.46, equivalent to the company's closing price on the Euronext Brussels on October 27, 2021. At the proposed deal size, MDxHealth would command a market value...read more